BOSTON--(BUSINESS WIRE)--PureTech Health plc (LSE: PRTC), a cross-disciplinary biopharmaceutical company, today announced that Daphne Zohar, PureTech Health’s Chief Executive Officer, will present at the Cowen and Company 37th Annual Health Care Conference on Monday, 6 March, at 3:20pm EST.
A webcast of the presentation will be available at http://puretechhealth.com/investors.php under the Reports and Presentations tab.
About PureTech Health
PureTech
Health (PureTech Health plc, PRTC.L) is a cross-disciplinary
biopharmaceutical company creating 21st century medicines
that modulate the adaptive human systems. Our therapies target the
immune, nervous, and gastro-intestinal systems by addressing the
underlying pathophysiology of disease from a systems perspective rather
than through a single receptor or pathway. We have multiple human
proof-of-concept studies and pivotal or registration studies expected to
read out in the next two years. PureTech Health’s rich and growing
research and development pipeline has been developed in collaboration
with some of the world’s leading scientific experts who, along with
PureTech's experienced team and board, analyze more than 650 scientific
discoveries per year to identify and advance only the opportunities we
believe hold the most promise for patients. This team and process place
PureTech Health on the cutting edge of ground-breaking science and
technological innovation and leads the Company between and beyond
existing disciplines. For more information, visit www.puretechhealth.com
or connect with us on Twitter.
Forward Looking Statement
This press release contains
statements that are or may be forward-looking statements, including
statements that relate to the company's future prospects, developments
and strategies. The forward-looking statements are based on current
expectations and are subject to known and unknown risks and
uncertainties that could cause actual results, performance and
achievements to differ materially from current expectations, including,
but not limited to, those risks and uncertainties described in the risk
factors included in the regulatory filings for PureTech Health plc.
These forward-looking statements are based on assumptions regarding the
present and future business strategies of the company and the
environment in which it will operate in the future. Each forward-looking
statement speaks only as at the date of this press release. Except as
required by law and regulatory requirements, neither the company nor any
other party intends to update or revise these forward-looking
statements, whether as a result of new information, future events or
otherwise.